Back Login for AI Analysis

    OCUL (STOCKS)

    Ocular Therapeutix, Inc.

    $9.076000
    +0.136000 (+1.52%)
    Prev close: $8.940000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Pharmaceuticals: Major
    CEO
    Pravin U. Dugel
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $1,969.55M
    Employees
    274
    P/E (TTM)
    -6.18
    P/B (TTM)
    3.36
    Dividend Yield
    Technical Indicators
    SMA 10
    SMA 20
    SMA 50
    EMA 9
    EMA 21
    RSI
    MACD State
    Recent News

    No recent news found for this ticker.

    Financial Statements
    TTM (Mar 2026)
    Revenues $52.04M
    Benefits Costs and Expenses $341.64M
    Cost Of Revenue $6.64M
    Costs And Expenses $351.48M
    Gross Profit $45.40M
    Nonoperating Income/Loss $8.94M
    Operating Expenses $344.84M
    Research and Development $220.45M
    Other Operating Expenses $124.38M
    Operating Income/Loss -$299.44M
    Income/Loss From Continuing Operations After Tax -$290.50M
    Income/Loss From Continuing Operations Before Tax -$289.78M
    Net Income/Loss -$290.50M
    Net Income/Loss Attributable To Noncontrolling Interest $0.00
    Net Income/Loss Attributable To Parent -$290.50M
    Net Income/Loss Available To Common Stockholders, Basic -$290.50M
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic $0.00
    Preferred Stock Dividends And Other Adjustments $0.00
    Basic Earnings Per Share -$1.44
    Diluted Earnings Per Share -$1.44
    Basic Average Shares 592,498,634
    Diluted Average Shares 592,498,634
    Assets $732.53M
    Current Assets $706.00M
    Inventory $3.74M
    Other Current Assets $702.26M
    Noncurrent Assets $26.53M
    Fixed Assets $18.43M
    Other Non-current Assets $8.11M
    Liabilities $150.96M
    Current Liabilities $47.68M
    Accounts Payable $8.03M
    Wages $8.03M
    Other Current Liabilities $31.62M
    Noncurrent Liabilities $103.27M
    Equity $581.57M
    Equity Attributable To Noncontrolling Interest $0.00
    Equity Attributable To Parent $581.57M
    Liabilities And Equity $732.53M
    Net Cash Flow From Operating Activities -$226.21M
    Net Cash Flow From Operating Activities, Continuing -$226.21M
    Net Cash Flow From Investing Activities -$14.61M
    Net Cash Flow From Investing Activities, Continuing -$14.61M
    Net Cash Flow From Financing Activities $557.83M
    Net Cash Flow From Financing Activities, Continuing $557.83M
    Net Cash Flow $317.02M
    Net Cash Flow, Continuing $317.02M
    Comprehensive Income/Loss -$290.50M
    Comprehensive Income/Loss Attributable To Noncontrolling Interest $0.00
    Comprehensive Income/Loss Attributable To Parent -$290.50M
    Other Comprehensive Income/Loss $0.00